Market Research Logo

Thailand Pharmaceuticals & Healthcare Q3 2018

Thailand Pharmaceuticals & Healthcare Q3 2018

BMI View:

Improvements to Thailand's regulatory environment, including medicine approval times, will support a greatermultinational presence over the long term. Sustaining this trend will be a confluence of the government's drive to foster innovationand the growing momentum within the pharmaceutical industry towards new medicine launches. However, pressure onpharmaceutical prices and aggressive cost-containment measures will continue to threaten the operations of multinationaldrugmakers in Thailand.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicines Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Divergent Regional Trends Will Shape Drugmaker Opportunities
Thailand Risk/Reward Index
Regulatory Development
Regulatory Overview
Market Overview
Competitive Landscape
Company Profile
Berlin Pharmaceutical Industry
Biolab
GlaxoSmithKline
Government Pharmaceutical Organization
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report